Mucous Membrane Pemphygoid (A Case Report)

Mucous membrane pemphigoid (mmp) is an otoimmun, cronic, inflamatuary, blastering disease. its clinical presentation may cover the oral mucosa, the ocular mucosa, the other mucous membrane and the skin. healing of the lesions, except the lesions of oral mucosa, occurs with skar tissue which may cause blindness when involves the conjuctiva. ocular mucosa is the most involved mucousa after oral mucosa. ophtalmologic consultation and following up of this patients is necessary. a multidisciplinary approach is essential in the managenet of mmp. early recognition and treatment may decrease disease-related complications. patients who have disease occuring in only oral mucosa are defined as “low risk” patients. nowadays, low group patients can be controlled by topical corticosteroids (tc), which have proved to be highly efficient and to cause fewer adverse effects compared with systemic corticosteroids. the effect of tc depends on its potency, concentration, pharmaceutical form and contact time between the drug and lesion. the medical status of the patient, the severity of the oral lesions, the extensiveness of the lesion and the experience of the clinician affect the choice of the special formulation, treatment regime and the potency of tcs which will be used in treatment of mmp limited in the oral mucosa. in this report clinical view of a 59 years old female patient with mmp who is treated with corticosteroids is presented.